SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-20-000620
Filing Date
2020-07-13
Accepted
2020-07-13 16:20:46
Documents
3
Group Members
ORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP VI LLCORBIMED ISRAEL GP II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss177735_sc13da.htm SC 13D/A 123707
2 JOINT FILING AGREEMENT ss177735_ex9901.htm EX-99.1 7662
3 LOCK-UP AGREEMENT ss177735_ex9903.htm EX-99.3 26585
  Complete submission text file 0000947871-20-000620.txt   159578
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Subject) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91200 | Film No.: 201025415
SIC: 2834 Pharmaceutical Preparations